drugset / Trial / NCT00446524

Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)

NCT00446524

Phase 3 Completed 403 enrolled Novartis
RandomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate long-term safety and tolerability of once daily administration of the combination of Valsartan and Amlodipine 80/5 mg for 52 weeks in patients with essential hypertension.

Timeline

Start
2007-02
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg
Subject Valsartan Small molecule 80 mg

Indications